In addition to Cantor Fitzgerald, Rocket Pharmaceuticals also received a Buy from TD Cowen’s Tyler Van Buren in a report issued today. However, on November 8, Goldman Sachs maintained a Hold rating on ...
Some results have been hidden because they may be inaccessible to you